BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 24995447)

  • 1. Coagulation.
    Chee YL
    J R Coll Physicians Edinb; 2014; 44(1):42-5. PubMed ID: 24995447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults.
    Kamal AH; Tefferi A; Pruthi RK
    Mayo Clin Proc; 2007 Jul; 82(7):864-73. PubMed ID: 17605969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An assessment of the utility of unselected coagulation screening in general hospital practice.
    McHugh J; Holt C; O'Keeffe D
    Blood Coagul Fibrinolysis; 2011 Mar; 22(2):106-9. PubMed ID: 21245744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring of dabigatran etexilate.
    Douxfils J; Mullier F; Robert S; Chatelain C; Chatelain B; Dogné JM
    Thromb Haemost; 2012 May; 107(5):985-97. PubMed ID: 22438031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into how blood clots: implications for the use of APTT and PT as coagulation screening tests and in monitoring of anticoagulant therapy.
    Bajaj SP; Joist JH
    Semin Thromb Hemost; 1999; 25(4):407-18. PubMed ID: 10548073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk of hemorrhage after adenoidectomy and tonsillectomy. Value of the preoperative determination of partial thromboplastin time, prothrombin time and platelet count].
    Scheckenbach K; Bier H; Hoffmann TK; Windfuhr JP; Bas M; Laws HJ; Plettenberg C; Wagenmann M
    HNO; 2008 Mar; 56(3):312-20. PubMed ID: 17581692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standardization and clinical utility of thrombin-generation assays.
    Berntorp E; Salvagno GL
    Semin Thromb Hemost; 2008 Oct; 34(7):670-82. PubMed ID: 19085768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of clotting screens.
    Thorell SE; Nash MJ; Thachil J
    Int J Lab Hematol; 2015 Feb; 37(1):8-13. PubMed ID: 24636194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardization of coagulation tests.
    Opartkiattikul N
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothermia and blood coagulation: dissociation between enzyme activity and clotting factor levels.
    Reed RL; Bracey AW; Hudson JD; Miller TA; Fischer RP
    Circ Shock; 1990 Oct; 32(2):141-52. PubMed ID: 2253317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombelastography is better than PT, aPTT, and activated clotting time in detecting clinically relevant clotting abnormalities after hypothermia, hemorrhagic shock and resuscitation in pigs.
    Martini WZ; Cortez DS; Dubick MA; Park MS; Holcomb JB
    J Trauma; 2008 Sep; 65(3):535-43. PubMed ID: 18784565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigation of coagulation time: PT and APTT].
    Ramakers C; van der Heul C; van Wijk EM
    Ned Tijdschr Geneeskd; 2012; 156(0):A3985. PubMed ID: 22917038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Suggestions and propositions to resolve some issues for standardization of prothrombin time and activated partial thromboplastin time].
    Kagawa K; Fukutake K
    Rinsho Byori; 1999 May; 47(5):431-7. PubMed ID: 10375964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Haemostatic testing prior to elective surgery? Yes!].
    Albert FW; Eichler H; Haubelt H; Loreth R; Matzdorff A; Peetz D; Pindur G; Schinzel H; Seyfert U; Hellstern P;
    Hamostaseologie; 2009 Jan; 29(1):58-63. PubMed ID: 19151848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of inaccurate blood sample volume on prothrombin time (PT) and activated partial thromboplastin time (aPTT).
    Peterson P; Gottfried EL
    Thromb Haemost; 1982 Apr; 47(2):101-3. PubMed ID: 7101228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated partial thromboplastin time: new tricks for an old dogma.
    Lippi G; Favaloro EJ
    Semin Thromb Hemost; 2008 Oct; 34(7):604-11. PubMed ID: 19085761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overuse of prothrombin and partial thromboplastin coagulation tests in medical inpatients.
    Pilsczek FH; Rifkin WD; Walerstein S
    Heart Lung; 2005; 34(6):402-5. PubMed ID: 16324959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance and causes of abnormal preoperative coagulation test results in children.
    Samková A; Blatný J; Fiamoli V; Dulíček P; Pařízková E
    Haemophilia; 2012 May; 18(3):e297-301. PubMed ID: 21967473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of preoperative blood coagulation analysis for assessment of hemorrhage risk in general surgery].
    Kussmann I; Koller M; Heinke T; Rothmund M
    Chirurg; 1997 Jul; 68(7):684-8. PubMed ID: 9340232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.